Clinical Investigation of Mandibular Implant Overdenture
NCT ID: NCT00066014
Last Updated: 2012-02-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
30 participants
INTERVENTIONAL
1998-11-30
2007-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Evaluation of NobelProcera Implant Bar Overdenture
NCT01720420
Mandibular Overdentures Retained by Mini Implants: a Clinical Trial Comparing Different Surgical and Loading Protocols
NCT04760457
Immediate Loading of 4 Guided Implants Supporting a Maxillary Overdenture Using a Novaloc TiN Retention System
NCT06083506
Mandibular Overdentures Retained by Conventional or Mini Implants
NCT01411683
Randomized Study For Minimally Invasive Splinted Implants
NCT02107612
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Information from this study will assist dental practitioners during treatment planning in selecting appropriate and cost effective treatment choices. There is an inverse relationship between edentulism in the U.S. population and socioeconomic status. If less costly and simplified treatment methods are shown to provide an equivalent treatment outcome to more costly/complex methods, these simplified treatments can be used to treat a larger percentage of the edentulous population.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
treatment modalities changed for comparison
All subjects experienced all treatment modalities being studied.
Implant Overdenture Treatment
All overdenture treatment modalities were provided to each subject using a crossover design.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Implant Overdenture Treatment
All overdenture treatment modalities were provided to each subject using a crossover design.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or female;
* At least one year of previous conventional complete denture treatment history;
* Willing to accept the conditions of the study and informed consent freely given;
* Ability to participate for 6 years;
* Able to understand and respond to self-reporting measurement scales used in the study;
* Minimum 20-mm interarch distance at the estimated vertical dimension of occlusion;
* Adequate bone quality;
* Adequate bone quantity to accommodate minimally four 3.75-mm diameter by 7-mm long Brånemark implants.
Exclusion:
* Administrative or physical considerations which would seriously affect the surgical procedure or construe a hindrance for a six-year involvement;
* History of drug or alcohol abuse;
* Excessive smoking (1+ pack/day);
* Uncontrolled systemic disease;
* Inability to undergo minor oral surgery because of health or personal reasons;
* Irradiated surgical site;
* Unrealistic expectations of the prosthodontic treatment outcome;
* Psychological or psychiatric conditions that could influence the subject's reaction to treatment;
* Acute or chronic TMD problems;
* pregnancy;
* Class II jaw relationship;
* Conventional dental treatment the treatment of choice.
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Dental and Craniofacial Research (NIDCR)
NIH
Nobel Biocare
INDUSTRY
Virginia Commonwealth University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David R Burns
Role: PRINCIPAL_INVESTIGATOR
Virginia Commonwealth University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Virginia Commonwealth University
Richmond, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIDCR-12204
Identifier Type: -
Identifier Source: org_study_id
NCT00000366
Identifier Type: -
Identifier Source: nct_alias
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.